Literature DB >> 7565467

Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients.

S Hara1, Y Ubara, K Arizono, H Ikeguchi, H Katori, A Yamada, Y Ogura, H Murata, N Mimura.   

Abstract

Radionuclide ventriculographic and echocardiographic assessments of left ventricular cardiac function were studied in 46 long-term maintenance hemodialysis patients, and comparison of cardiac function pre- and post-parathyroidectomy in 10 hemodialysis patients with secondary hyperparathyroidism was investigated. In long-term hemodialysis patients, impairment of cardiac function was observed in 80.4%. In an overall study of 46 patients, no correlation between intact parathyroid hormone (iPTH) level and left ventricular ejection fraction (LVEF) was observed, but a significant (p < 0.05) negative correlation was observed in patients with an iPTh blood level over 200 pg/ml. A negative correlation between fractional fiber shortening and an iPTh level over 200 pg/ml was observed (p < 0.05). There was neither a correlation between the iPTH level and left ventricular (LV) mass, nor was there a correlation between the iPTH level and wall thickness. After parathyroidectomy, systolic and diastolic blood pressure, cardiothoracic ratio, LVEF, and LV mass decreased significantly (p < 0.05), but no significant difference was detected in cardiac thickness. In summary, the present data suggest that high levels over 200 pg/ml of the iPTH in long-term hemodialysis patients adversely affect the myocardial function, induce cardiac hypertrophy and cause high arterial blood pressure. After parathyroidectomy, the cardiac function improved with a reduction of cardiac mass and an improvement of cardiac contraction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565467

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  3 in total

Review 1.  Left ventricular hypertrophy and chronic renal insufficiency in the elderly.

Authors:  David Leibowitz
Journal:  Cardiorenal Med       Date:  2014-09-17       Impact factor: 2.041

2.  Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease.

Authors:  Anton Lishmanov; Smrita Dorairajan; Youngju Pak; Kunal Chaudhary; Anand Chockalingam
Journal:  Int Urol Nephrol       Date:  2011-02-15       Impact factor: 2.370

3.  Effect of intermittent versus continuous parathyroid hormone in the cardiovascular system of rats.

Authors:  Sanela Smajilovic; Rasmus Schaal-Jensen; Reza Jabbari; Una Smajilovic; Stig Haunso; Jacob Tfelt-Hansen
Journal:  Open Cardiovasc Med J       Date:  2010-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.